I. Introduction
The term Metabolic Syndrome was first used by J. P. Camus (1966) who revealed the connection between diabetes mellitus, hyperlipoproteinemia and gout with high cardiovascular risk.
(1) Twenty years later Raeven described Syndrome X (diabetes mellitus, dyslipidemia: hypertriglyceridemia with the reduction of HDL cholesterol, arterial hypertension and insulin resistance). (2) In 1999 WHO introduced the name Metabolic Syndrome X (3, 4) and established it as a distinct clinical entity. A group of metabolic and physiological risk factors with specific cut off values which are linked to cardiovascular disorders (CVD) has been variously termed as the insulin resistance syndrome, the metabolic syndrome, the dysmetabolic syndrome. (5) (6) (7) (8) (9) (10) (11) (12) The metabolic syndrome is one of the major public health issues of this century. The presence of MS is associated with an increased risk of coronary heart disease. (13, 14) Proposed definitions of the metabolic syndrome have differed with respect to components and their cut points. In the present study, we have examined the prevalence and association of metabolic syndrome and its individual components in patients admitted with myocardial infarction (MI).
Obesity is largely prevalent in our country. Studies are ongoing to validate the cut off values, used by the international bodies, among Asian Indians. This effort is to identify patients at risk for diabetes and CVD due to overweight or obesity. In our study we have also tried to see the prevalence and significance of association of WHR and BMI in patients with AMI.
II. Materials and Methods
This hospital-based, cross-sectional study was conducted in the Department of Cardiology, Calcutta National Medical College and Hospital (CNMC&H), Kolkata, West Bengal. The study was carried out from March 2004 to July 2005. 76 patients admitted in the coronary care unit, who were diagnosed as having AMI as per the WHO criteria, were included in the study. Blood samples were drawn at admission for creatine kinasetotal and creatine kinase-MB isoenzyme. The following morning, samples for triglyceride and HDL-C were collected, and on day 3, a sample for estimation of blood glucose level was collected. All the biochemical tests are done at the biochemistry department of CNMC&H. Waist-circumference and blood pressure were recorded in all subjects.
We have used the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) recommendations for defining the MS which consists of any three of the following 5 component conditions: hypertriglyceridemia (HTG), low HDL cholesterol (HDL-C), hypertension (HTN), abdominal obesity, and insulin resistance (IR). (15) IR was defined as fasting glucose ≥110 mg/dL or by a self-report of current use of insulin or oral hypoglycemics. HTN was defined as systolic blood pressure ≥ 130 mm Hg . HTN may also can be diagnosed if diastolic blood pressure ≥ 85 mm Hg or by a self-report of current use of anti-HTN medication. HTG was identified based on triglycerides ≥ 150 mg/dL. Low HDL-C was identified by HDL cholesterol < 40 mg/dL in men or < 50 mg/dL in women. High WC was defined as a WC > 102 cm in men or > 88 cm in women. The present study was based on a subset of subjects aged 20 to 89 years. The WC of subjects were measured using a measuring tape positioned at the high point of the iliac crest. The measurement was made at minimal respiration to the nearest 0.1 cm, with the tape snug but not compressing the skin. Subject age, race, and cigarette smoking outcome were collected in a structured interview. A minimum age cut off of 20 years is consistent with the NCEP-ATP-III definition of young adult.
To determine if there is a statistically significant difference we used t-test for independent samples. Data was analyzed using the Student's t test and the Chi-square test.
II.
Results and Analysis table 1 and  table 2 . The prevalence of each component conditions (insulin resistance, hypertension, abdominal obesity measured by waist circumference, hypertriglyceridemia and low HDL cholesterol) are more common in cases in both the male and female groups compared with controls. All results are statistically significant except for abdominal obesity measured by high waist circumference [p>0.05] which was not independently related to the prevalent disease. Table-1 shows the prevalence of the component conditions and the full metabolic syndrome among subjects with and without prevalent disease, both in male and females. There is no significant difference in prevalence of MS among male and female cases of AMI. Table-2 shows the sex specific association of MI with the full metabolic syndrome and its component conditions, adjusted for age, sex, race, and smoking status. The metabolic syndrome was significantly associated with MI in both men (OR, 10.50; 95% CI,) and women (OR, 13.24; 95% CI,). All the component conditions of metabolic syndrome were significantly associated with MI except abdominal obesity, measured by waist circumference.
Among the component conditions insulin resistance had the highest OR in men and low HDL had the highest OR in women. An interesting finding of other obesity markers was revealed in this study. When analysing the association of BMI with MI, our study reveal that their relation were not statistically significant. But when central obesity was measured by waist hip ratio of >0.09 our study revealed that they were significantly related to MI and that holds true in both male and female group.
IV. Discussion
The present study was a hospital based comparative case control study conducted in National Medical College and Hospital, a tertiary care hospital of Calcutta, West Bengal, serving an urban and suburban population. In the present study, we found that the metabolic syndrome was significantly associated with AMI in both sexes. These findings suggest that the metabolic syndrome has clinical utility in identifying patients at increased risk of AMI. Similar findings have been noted by John K. Ninomiya in his analysis of Third National Health and Nutrition Examination Survey where MS is significantly associated with AMI. (16) a few similar studies have reported higher cardiovascular risk in subjects with MS . (17, 18) Among the components of MS all are novel risk factors for AMI and among them hypertension, insulin resistance, low HDL and high triglyceride are significantly present in patients of AMI in both the sexes. But there is lack of association between abdominal obesity (high WC) and prevalent disease. Also when taking into consideration of other obesity markers, statistical significance do not reach for body mass index [BMI] but the waist hip ratio [WHR] reached statistical significance. This differs from some previous studies that have reported linear relationships between coronary heart disease and either BMI or WHR. (19) Though the recent INTERHEART study showed that waist-to-hip ratio was a much better predictor of CVD events than BMI. (20) This finding may reflect an indirect effect of high WC through other components of the syndrome or may be due to higher cut off values used to determine obesity. It must be emphasized that While it is clear that obesity measured by any index almost always correlates with cardiovascular disease risk (CVD) risk factors, there are differences in the relationship of these anthropometric measures and CVD risk factors in different ethnic groups. (21) It is seen that Asian Indians have an increased predisposition not only to diabetes (22) but also to premature coronary artery disease. (23) This has been attributed to the so called "Asian Indian Phenotype" of obesity characterized by less of generalized obesity as measured by body mass index (BMI) but greater central body obesity as measured by greater WC and WHR. (24, 25) Obesity is a major driver for the widely prevalent metabolic syndrome and type 2 diabetes mellitus (T2DM) in Asian Indians in India and those residing in other countries. In this study the lack of association of BMI and WC with the prevalent disease , AMI, may be due to the use of higher cut off values used in this study , which have used the cut offs based on Caucasian population. This study also emphasizes the need for determining Asian Indian specific cut offs for obesity. Based on percentage body fat and morbidity data, limits of normal BMI are narrower and lower in Asian Indians than in white Caucasians.
We also like to emphasize that large scale prospective studies are required to know the influence of MS on the outcome or case fatality rates in AMI.
V. Conclusion
So we like to conclude that our study had found significant association between the metabolic syndrome and AMI. In addition, with the exception of high WC, all of the component conditions of the metabolic syndrome were significantly associated with AMI. These findings clinches the importance of the metabolic syndrome as a significant risk factor for cardiovascular disease. This reaffirms the need to develop stringent strategies for controlling this syndrome and also its individual components. This study also indicates the need to develop Asian Indian specific cut off values for determining obesity. 
